Lonza Executive and Leadership Team

Robert Whitelaw, the President & Chief Executive Officer (Japan) at Lonza, spearheads the company's strategic direction and operational execution within the Japanese market. This leadership role encompasses driving business development, managing regional P&L, and ensuring alignment with Lonza's global objectives in serving the pharmaceutical, biotech, and specialty ingredients sectors. Whitelaw oversees the expansion of services and products, including active pharmaceutical ingredients and microbial control technologies, tailored to regional demands. The President & Chief Executive Officer (Japan) fosters key relationships with local partners and stakeholders, navigating the unique business landscape to maximize market penetration and revenue growth. By championing Lonza's commitment to innovation and global health, Robert Whitelaw ensures robust performance and strategic positioning within Japan.

Mary Lucero, the Chief Financial Officer at Lonza, oversees all financial operations and strategic financial planning for the global enterprise. This critical position involves managing capital allocation, financial reporting, and investor relations, ensuring fiscal health and driving sustainable growth across Lonza's diverse market segments. Lucero's responsibilities extend to optimizing financial performance for both the Pharma & Biotech and Specialty Ingredients divisions, supporting the development and delivery of products like active pharmaceutical ingredients and nutritional ingredients. The Chief Financial Officer plays a pivotal role in evaluating investment opportunities and managing financial risks, thereby safeguarding the company's assets and enhancing shareholder value. Through rigorous financial oversight, Mary Lucero directly supports Lonza's mission of innovation and its impact on global health and industrial preservation.

Marcello Giora, the Region General Manager & Chief Financial Officer (South America) at Lonza, directs both the overall business strategy and financial management for the South American region. This dual mandate involves overseeing operational expansion, driving revenue growth, and ensuring fiscal discipline across Lonza's diverse product and service offerings in the region, including pharmaceutical ingredients and industrial preservatives. Giora's financial acumen supports strategic investments and resource allocation, optimizing profitability and market share within South America. The Region General Manager & Chief Financial Officer (South America) also leads market-specific initiatives, adapting Lonza's global portfolio to meet local needs and regulatory requirements. Through this comprehensive leadership, Marcello Giora significantly contributes to Lonza's global presence and its mission to advance health and safety.

Margaret McDonald, the Executive Vice President & Chief Financial Officer at Lonza, provides overarching financial leadership and strategic fiscal direction for the entire global organization. This executive role involves shaping financial policy, managing corporate finance, and driving key financial strategies that support Lonza's mission across the pharmaceutical, biotech, and specialty ingredients markets. McDonald's oversight extends to optimizing financial performance, ensuring robust capital management, and guiding investment decisions for critical areas such as active pharmaceutical ingredients and microbial control technologies. The Executive Vice President & Chief Financial Officer collaborates closely with other C-suite leaders to align financial objectives with operational goals, thereby enhancing efficiency and fostering sustainable growth. Through expert financial stewardship, Margaret McDonald ensures Lonza's continued innovation and its vital contribution to global health and industrial solutions.

Jean-Paul Ouellette, the Chief of Staff at Lonza, directs strategic initiatives and operational alignment across the organization. This role involves translating high-level corporate objectives into actionable plans, ensuring seamless execution of the company's mission to serve pharmaceutical, biotech, and specialty ingredients markets. Ouellette coordinates cross-functional teams to optimize service and product delivery, including active pharmaceutical ingredients and microbial control technologies. The Chief of Staff facilitates communication between executive leadership and various departments, driving efficiency and fostering a cohesive operational environment. By managing key projects and advising executive decision-making, Jean-Paul Ouellette ensures Lonza's strategic priorities are met, contributing directly to the company's commitment to innovation and global health advancement.